{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=morphine&page=18", "query": { "intervention": "morphine", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 910, "total_pages": 91, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=morphine&page=19&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=morphine&page=17&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-19T09:44:21.751Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01507233", "title": "A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bowel Obstruction" ], "interventions": [ { "name": "IV morphine sulfate", "type": "DRUG" }, { "name": "EXPAREL (bupivacaine liposome injectable suspension)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pacira Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2012-05", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2014-03-06", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01507233" }, { "nct_id": "NCT05488847", "title": "Opioid-Free Pain Protocol After Shoulder Arthroplasty", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Shoulder Arthropathy", "Shoulder Pain" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ropivicaine", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Tizanidine", "type": "DRUG" }, { "name": "Magnesium", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxycodone Hydrochloride 5 Mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2022-06-25", "completion_date": "2026-09-01", "has_results": true, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05488847" }, { "nct_id": "NCT05463367", "title": "Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Opioid Use", "Opioid Dependence", "Opioid-use Disorder", "Narcotic Use", "Back Pain", "Back Injuries", "Chronic Pain", "Chronic Low-back Pain", "Pain, Chronic", "Pain;Back Low;Chronic", "Pain, Back" ], "interventions": [ { "name": "Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet", "type": "DRUG" }, { "name": "Naproxen 500 Mg", "type": "DRUG" }, { "name": "Opioids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2021-01-01", "completion_date": "2025-06-01", "has_results": false, "last_update_posted_date": "2024-11-27", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05463367" }, { "nct_id": "NCT00420992", "title": "A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Osteoarthritis", "Chronic Pain" ], "interventions": [ { "name": "ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 547, "start_date": "2006-12", "completion_date": "2007-11", "has_results": true, "last_update_posted_date": "2013-09-20", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Peoria, Arizona + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00420992" }, { "nct_id": "NCT06940570", "title": "Methadone as an Alternative Treatment for Children Underdoing HSCT", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Leukemia", "Aplastic Anemia", "Bone Marrow Failure Syndromes", "SCID" ], "interventions": [ { "name": "PCA plus methadone (Experimental)", "type": "DRUG" }, { "name": "PCA Alone (SOC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Years to 18 Years" }, "enrollment_count": 60, "start_date": "2028-01-01", "completion_date": "2029-08-01", "has_results": false, "last_update_posted_date": "2025-10-23", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06940570" }, { "nct_id": "NCT03472469", "title": "MAST Trial: Multi-modal Analgesic Strategies in Trauma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Nonspecific Pain Post Traumatic Injury" ], "interventions": [ { "name": "Acetaminophen IV/PO", "type": "DRUG" }, { "name": "Acetaminophen PO", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Celebrex", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Opioids", "type": "DRUG" }, { "name": "Regional anesthesia", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 1561, "start_date": "2018-04-02", "completion_date": "2019-07-03", "has_results": true, "last_update_posted_date": "2021-06-18", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03472469" }, { "nct_id": "NCT01740492", "title": "Low Dose Ketamine for Management of Acute Severe Pain in the Emergency Department", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Ketamine 0.15mg/kg", "type": "DRUG" }, { "name": "Ketamine 0.3mg/kg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Rhode Island Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 75, "start_date": "2012-09", "completion_date": "2014-06", "has_results": false, "last_update_posted_date": "2022-09-07", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT01740492" }, { "nct_id": "NCT03574792", "title": "Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8", "Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Methadone", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Venlafaxine", "type": "DRUG" }, { "name": "Venlafaxine Hydrochloride Extended Release", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2018-05-03", "completion_date": "2021-11-11", "has_results": true, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03574792" }, { "nct_id": "NCT01081912", "title": "Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Back Pain Lower Back Chronic" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Hydrocodone bitartrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zogenix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 510, "start_date": "2010-03", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2022-12-08", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 51, "location_summary": "Phoenix, Arizona • Jonesboro, Arkansas • Anaheim, California + 47 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Laguna Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01081912" }, { "nct_id": "NCT01100086", "title": "A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Reformulated OXY (oxycodone HCl)", "type": "DRUG" }, { "name": "Original OxyContin® (OXY) (oxycodone HCl)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Purdue Pharma LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 84, "start_date": "2007-01", "completion_date": "2007-06", "has_results": true, "last_update_posted_date": "2010-05-25", "last_synced_at": "2026-10-19T09:44:21.751Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01100086" } ] }